Leo H. Evart Inc’s Medtronic MDT Stock Holding History

Leo H. Evart Inc’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$156	Hold	2	–	–	﹤0.01%	265
2026 Q1	$173	Buy	+2	New	+$192	﹤0.01%	265

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Leo H. Evart Inc's MDT Position: Q2 2026 in Review

Leo H. Evart Inc held its Medtronic (MDT) position steady in Q2 2026 at 2 shares worth $156. The position accounts for ﹤0.01% of the portfolio, ranked #265.

Leo H. Evart Inc first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. The position peaked at $173 in Q1 2026. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Leo H. Evart Inc held 2 shares of Medtronic worth $156 as of Q2 2026.
Leo H. Evart Inc left its Medtronic share count unchanged in Q2 2026.
Medtronic made up ﹤0.01% of Leo H. Evart Inc's portfolio in Q2 2026, its #265 holding.
Leo H. Evart Inc first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
Leo H. Evart Inc's Medtronic position peaked at $173 in Q1 2026.
2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Leo H. Evart Inc's 13F filing for Q2 2026, filed 18 Aug 2026.